Published in Ann Surg on February 01, 2001
The value of residual liver volume as a predictor of hepatic dysfunction and infection after major liver resection. Gut (2005) 2.82
Guidelines for resection of colorectal cancer liver metastases. Gut (2006) 2.35
Impact of preoperative planning using virtual segmental volumetry on liver resection for hepatocellular carcinoma. World J Surg (2007) 1.35
Liver volumetry plug and play: do it yourself with ImageJ. World J Surg (2007) 1.34
Liver manipulation causes hepatocyte injury and precedes systemic inflammation in patients undergoing liver resection. World J Surg (2007) 1.20
Virtual liver resection and volumetric analysis of the future liver remnant using open source image processing software. World J Surg (2010) 1.18
Assessment of intraoperative liver deformation during hepatic resection: prospective clinical study. World J Surg (2010) 1.12
Feasibility of navigated resection of liver tumors using multiplanar visualization of intraoperative 3-dimensional ultrasound data. Ann Surg (2007) 1.07
The adaptive response of the reticuloendothelial system to major liver resection in humans. Ann Surg (2006) 1.05
Prospective volumetric assessment of the liver on a personal computer by nonradiologists prior to partial hepatectomy. World J Surg (2011) 1.04
Assessment of hepatic functional reserve by cirrhosis grading and liver volume measurement using CT. World J Gastroenterol (2007) 0.99
Liver resection for cancer. World J Gastroenterol (2001) 0.97
Techniques, clinical applications and limitations of 3D reconstruction in CT of the abdomen. Korean J Radiol (2004) 0.97
Peritoneal volume is predictive of tension-free fascia closure of large incisional hernias with loss of domain: a prospective study. Hernia (2011) 0.97
Liver tissue sparing resection using a novel planning tool. Langenbecks Arch Surg (2010) 0.85
C-reactive protein concentration is associated with prognosis in patients suffering from peritoneal carcinomatosis of colorectal origin. Int J Colorectal Dis (2011) 0.81
Novel 3-dimensional virtual hepatectomy simulation combined with real-time deformation. World J Gastroenterol (2015) 0.80
Serial volumetric assessment of large for size liver grafts after whole cadaveric liver transplant in adults: do large liver grafts shrink in size? HPB (Oxford) (2015) 0.78
Application of a visible simulation surgery technique in preoperation planning for intrahepatic calculi. World J Surg (2010) 0.76
The role of three-dimensional imaging in optimizing diagnosis, classification and surgical treatment of hepatocellular carcinoma with portal vein tumor thrombus. HPB (Oxford) (2015) 0.76
Integration of Child-Pugh score with future liver remnant yields improved prediction of liver dysfunction risk for HBV-related hepatocellular carcinoma following hepatic resection. Oncol Lett (2017) 0.75
Adult-to-adult living donor liver transplantation using extended right lobe grafts. Ann Surg (1997) 2.44
Accurate measurement of liver, kidney, and spleen volume and mass by computerized axial tomography. Ann Intern Med (1979) 2.11
Prediction of the safe limits of hepatectomy by combined volumetric and functional measurements in patients with impaired hepatic function. Surgery (1984) 1.86
Measurement of liver and spleen volume by computed tomography. Assessment of reproducibility and changes found following a selective distal splenorenal shunt. Radiology (1981) 1.65
Recent advances in the isolation of liver cells. Hepatology (1994) 1.63
Indocyanine green clearance as a predictor of successful hepatic resection in cirrhotic patients. Am J Surg (1992) 1.63
Virtual reality applied to hepatic surgery simulation: the next revolution. Ann Surg (1998) 1.63
Functional analysis of grafts from living donors. Implications for the treatment of older recipients. Ann Surg (1996) 1.51
Estimation of the functional reserve of human liver. Ann Surg (1974) 1.49
Preoperative portal vein embolization for extension of hepatectomy indications. Hepatology (1996) 1.46
Changes in hepatic lobar function after right portal vein embolization. An appraisal by biliary indocyanine green excretion. Ann Surg (1996) 1.35
Lignocaine metabolite formation as a measure of pre-transplant liver function. Lancet (1989) 1.23
Antipyrine, paracetamol, and lignocaine elimination in chronic liver disease. Br Med J (1977) 1.06
Does the subspecialty of the surgeon performing primary colonic resection influence the outcome of patients with hepatic metastases referred for resection? Ann Surg (1999) 0.99
Significance of liver size in hepatic surgery. HPB Surg (1997) 0.98
Development of a computer-aided surgery system: three-dimensional graphic reconstruction for treatment of liver cancer. Surgery (1991) 0.96
Rates of formation and thermal stabilities of RNA:DNA and DNA:DNA duplexes at high concentrations of formamide. Nucleic Acids Res (1977) 15.92
Climate variability and North Sea cod. Nature (2000) 3.41
Bile duct injury in the era of laparoscopic cholecystectomy. Br J Surg (2006) 3.36
Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies. Br J Cancer (2006) 3.26
Superior staging of liver tumors with laparoscopy and laparoscopic ultrasound. Ann Surg (1994) 2.98
Multipractice analysis of laparoscopic cholecystectomy in 1,983 patients. Am J Surg (1992) 2.87
The value of residual liver volume as a predictor of hepatic dysfunction and infection after major liver resection. Gut (2005) 2.82
Evidence for high-energy extraterrestrial neutrinos at the IceCube detector. Science (2013) 2.56
Mitochondrial nucleic acids in the petite colonie mutants: deletions and repetition of genes. Biochimie (1973) 2.45
Sequence homology between mitochondrial DNAs of different eukaryotes. Biochemistry (1975) 2.32
Major hepatic resection under total vascular exclusion. Ann Surg (1989) 2.29
Acute-phase protein response and survival duration of patients with pancreatic cancer. Cancer (1995) 2.09
First observation of PeV-energy neutrinos with IceCube. Phys Rev Lett (2013) 2.00
Carcinoma of the pancreatic head and periampullary region. Tumor staging with laparoscopy and laparoscopic ultrasonography. Ann Surg (1995) 1.96
Initial experience with a multimodal enhanced recovery programme in patients undergoing liver resection. Br J Surg (2008) 1.93
Hybridization of mitochondrial transfer RNA's with mitochondrial and nuclear DNA of grande (wild type) yeast. J Mol Biol (1972) 1.90
The administration of an oral carbohydrate-containing fluid prior to major elective upper-gastrointestinal surgery preserves skeletal muscle mass postoperatively--a randomised clinical trial. Clin Nutr (2005) 1.88
Androgen responses during physical exercise. Br Med J (1973) 1.87
Liver resection and transplantation in the management of iatrogenic biliary injury. World J Surg (2007) 1.83
Sequence homology of the mitochondrial leucyl-tRNA cistron in different organisms. Biochemistry (1975) 1.82
Laparoscopic cholecystectomy. Br J Surg (1991) 1.70
Association between early systemic inflammatory response, severity of multiorgan dysfunction and death in acute pancreatitis. Br J Surg (2006) 1.69
Laser-assisted laparoscopic excision of liver cyst. Br J Surg (1991) 1.68
Issues of consent in renal transplantation. Ann R Coll Surg Engl (2001) 1.68
The use of operative ultrasound in surgery of primary liver tumors. World J Surg (1987) 1.64
The outcome of the first 165 orthotopic liver transplants in Scotland. Scott Med J (1999) 1.63
X-linked mental retardation associated with macro-orchidism. J Med Genet (1975) 1.62
Treatment of severe diabetes mellitus by insulin infusion. Br Med J (1974) 1.61
Open cholecystectomy in the laparoscopic era. Br J Surg (2007) 1.56
Cytokine regulation of constitutive production of interleukin-8 and -6 by human pancreatic cancer cell lines and serum cytokine concentrations in patients with pancreatic cancer. Int J Oncol (2002) 1.53
A comparative study of emergency transjugular intrahepatic portosystemic stent-shunt and esophageal transection in the management of uncontrolled variceal hemorrhage. Am J Gastroenterol (1995) 1.52
TIPSS 10 years on. Gut (2000) 1.48
Elevation of intracranial pressure following transjugular intrahepatic portosystemic stent-shunt for variceal haemorrhage. J Hepatol (1997) 1.48
Segment III cholangiojejunostomy for palliation of malignant hilar obstruction. Br J Surg (1994) 1.46
Laparoscopic ultrasonography in the evaluation of the biliary tree during laparoscopic cholecystectomy. Br J Surg (1994) 1.44
Changing management of pyogenic liver abscess. Br J Surg (1996) 1.40
Randomized clinical trial of laxatives and oral nutritional supplements within an enhanced recovery after surgery protocol following liver resection. Br J Surg (2010) 1.39
A randomized trial comparing transjugular intrahepatic portosystemic stent-shunt with variceal band ligation in the prevention of rebleeding from esophageal varices. Hepatology (1997) 1.39
Bleeding ectopic varices in cirrhosis: the role of transjugular intrahepatic portosystemic stent shunts. Aliment Pharmacol Ther (2008) 1.38
Role of the surgical trainee in upper gastrointestinal resectional surgery. Ann R Coll Surg Engl (1999) 1.34
Segmental liver resection using ultrasound-guided selective portal venous occlusion. Ann Surg (1989) 1.32
Prognostic factors in the palliation of pancreatic cancer. Eur J Surg Oncol (2003) 1.28
Preoperative lymphocyte count as a prognostic factor in resected pancreatic ductal adenocarcinoma. HPB (Oxford) (2007) 1.26
The use of umbilical cord blood in mismatched related and unrelated hemopoietic stem cell transplantation. Blood Cells (1994) 1.22
Bacterial superantigens--mechanism of T cell activation by the superantigens and their role in the pathogenesis of infectious diseases. Microbiol Immunol (1994) 1.22
Incidence of benign pathology in patients undergoing hepatic resection for suspected malignancy. Surgeon (2003) 1.20
Morphogenesis of the epidermis of adult abdomen of Drosophila. J Embryol Exp Morphol (1980) 1.20
Study of the biological activities of toxic shock syndrome toxin-1: II. Induction of the proliferative response and the interleukin 2 production by T cells from human peripheral blood mononuclear cells stimulated with the toxin. Clin Exp Immunol (1987) 1.19
Postchemoembolisation syndrome--tumour necrosis or hepatocyte injury? Br J Cancer (2003) 1.19
Activation of murine T cells by toxic shock syndrome toxin-1. The toxin-binding structures expressed on murine accessory cells are MHC class II molecules. J Immunol (1989) 1.19
Meta-analysis of the value of somatostatin and its analogues in reducing complications associated with pancreatic surgery. Br J Surg (2005) 1.18
Tailoring the management of nonparasitic liver cysts. Ann Surg (1998) 1.17
Early specialist repair of biliary injury. Br J Surg (2006) 1.09
Glutamine-supplemented total parenteral nutrition enhances T-lymphocyte response in surgical patients undergoing colorectal resection. Ann Surg (1994) 1.09
Reduction in renal blood flow following acute increase in the portal pressure: evidence for the existence of a hepatorenal reflex in man? Gut (1997) 1.09
Superantigenic properties of a novel mitogenic substance produced by Yersinia pseudotuberculosis isolated from patients manifesting acute and systemic symptoms. J Immunol (1993) 1.08
Transjugular intrahepatic portosystemic stent shunt (TIPSS): early clinical experience. Clin Radiol (1992) 1.07
Supervised surgical trainees can perform pancreatic resections safely. J R Coll Surg Edinb (1999) 1.07
An audit of the management of patients with acute pancreatitis against national standards of practice. Br J Surg (2007) 1.05
Changing trends in the management of extrahepatic cholangiocarcinoma. Br J Surg (1993) 1.05
Adult medulloblastoma: feasibility and effectiveness of utilising high-dose chemotherapy with autologous stem cell rescue in newly diagnosed patients. Intern Med J (2014) 1.05
Synthesis of mitochondrial and nuclear DNA in anerobically grown yeast during the development of mitochondrial function in response to oxygen. J Mol Biol (1969) 1.04
Implantation of IL-2-containing osmotic pump prolongs the survival of superantigen-reactive T cells expanded in mice injected with bacterial superantigen. J Immunol (1996) 1.04
Development of quinolone resistance and multiple antibiotic resistance in Salmonella bovismorbificans in a pancreatic abscess. J Antimicrob Chemother (1991) 1.04
Activation of human T cells by toxic shock syndrome toxin-1: the toxin-binding structures expressed on human lymphoid cells acting as accessory cells are HLA class II molecules. Eur J Immunol (1989) 1.04
Correlation of immune and nutritional status with wound complications in patients undergoing vascular operations. Surgery (1983) 1.03
Insulin and counterregulatory hormones influence acute-phase protein production in human hepatocytes. Am J Physiol (1995) 1.03
Needle track seeding of primary and secondary liver carcinoma after percutaneous liver biopsy. HPB Surg (1993) 1.03
Role of serum endotoxin and antiendotoxin core antibody levels in predicting the development of multiple organ failure in acute pancreatitis. Br J Surg (1993) 1.03
Laparoscopic ultrasonography: extending the scope of diagnostic laparoscopy. Br J Surg (1994) 1.02
Characterization of mitochondrial deoxyribonucleic acid from a series of petite yeast strains by deoxyribonucleic acid-deoxyribonucleic acid hybridization. Biochemistry (1974) 1.02
Cholangiocarcinoma arising after biliary-enteric drainage procedures for benign disease. Gut (2002) 1.01
Hepatic resection for benign non-cystic liver lesions. HPB (Oxford) (2004) 1.01
Effect of femoral component designs on the contact and tracking characteristics of the unresurfaced patella in total knee arthroplasty. Can J Surg (2001) 1.01
A comparison between gastric and oesophageal variceal haemorrhage treated with transjugular intrahepatic portosystemic stent shunt (TIPSS). Aliment Pharmacol Ther (1997) 1.00
Segmental surgery of the liver. Surg Annu (1988) 1.00
Early experience of laparoscopic ultrasonography in the management of pancreatic carcinoma. Surg Endosc (1993) 1.00
Does the subspecialty of the surgeon performing primary colonic resection influence the outcome of patients with hepatic metastases referred for resection? Ann Surg (1999) 0.99
Tryptophan catabolites in mesenteric lymph may contribute to pancreatitis-associated organ failure. Br J Surg (2008) 0.98
Transjugular intrahepatic portosystemic stent-shunt (TIPSS): long-term follow-up. QJM (1994) 0.98
Case report: prolapse of an ampullary tumour beyond the duodeno-jejunal flexure. Clin Radiol (1993) 0.98
Hybridization of mitochondrial transfer RNA and mitochondrial DNA in petite mutants of yeast. J Mol Biol (1972) 0.98
Benefits of specialisation in the management of pancreatic cancer: results of a Scottish population-based study. Br J Cancer (2004) 0.98
Liver resection for cancer. World J Gastroenterol (2001) 0.97
An 8-year experience of hepatic resection: indications and outcome. Br J Surg (1998) 0.97
Relative strength of the mitogenic and interleukin-2-production-inducing activities of staphylococcal exotoxins presumed to be causative exotoxins of toxic shock syndrome: toxic shock syndrome toxin-1 and enterotoxins A, B and C to murine and human T cells. Clin Exp Immunol (1989) 0.97
Clinical prognostic scoring system to aid decision-making in gastro-oesophageal cancer. Br J Surg (2007) 0.97
Mucinous cystic neoplasms of the pancreas: imaging features and diagnostic difficulties. Clin Radiol (2000) 0.96